ANXIETY

Brand Owner (click to sort) Address Description
ANXIETY COACH Anxiety Treatment Center, Ltd. 951 Plum Grove Road Suite C Schaumburg IL 60173 ANXIETY;ELECTRONIC NEWSLETTER FEATURING INFORMATION ABOUT ANXIETY DISORDERS ACCESSIBLE VIA GLOBAL COMPUTER NETWORK;
ANXIETY RELIEVR APPLIEDVR, INC. 1840 Century Park East, Suite 801 Los Angeles CA 90067 ANXIETY;Design and development of customized virtual reality software in the field of computer applications and mobile applications for use in patient health management;
ANXIETY.ORG Alorad, Inc. Suite 200 25 Enterprise Aliso Viejo CA 92656 ANXIETY;Providing a website via a global computer network featuring information and comprehensive content in the field of anxiety disorder ; Providing a website featuring information in the field of the diagnosis and treatment of anxiety disorder;
ANXITEE Xie Zhifa No. 3, Dingxi, Gushan Village, Chengxiang Town, Anxi County, Fujian Province 362400 China ANXIETY;The wording ANXITEE has no meaning in a foreign language.;Bottle racks; Clothes hangers; Coatstands; Flower-pot pedestals; Flower-stands; Furniture shelves; Furniture of metal; Magazine racks; Newspaper display stands; Storage racks;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention is directed to indolone derivatives which are selective antagonists for the GalR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GalR3 receptor antagonist.